Print

Bayer HealthCare AG (BAY) Receives FDA Approval For Room Temperature Storage Of Kogenate(R) FS 
10/19/2005 5:13:18 PM

BERKELEY, Calif.--(BUSINESS WIRE)--Oct. 6, 2005--The Biological Products Division of Bayer HealthCare, LLC., (Bayer BP) announced today that Kogenate(R) FS (Antihemophilic Factor (Recombinant), Formulated with Sucrose) received approval to be stored at room temperature (77 degrees F, 25 degrees C) for up to three months. The new storage guidelines for the treatment will provide users with greater flexibility and simplify storage options.
//-->